DE69630727D1 - Radioaktiven Chitosankomplex und deren Anwendung in Strahlungstherapie - Google Patents

Radioaktiven Chitosankomplex und deren Anwendung in Strahlungstherapie

Info

Publication number
DE69630727D1
DE69630727D1 DE69630727T DE69630727T DE69630727D1 DE 69630727 D1 DE69630727 D1 DE 69630727D1 DE 69630727 T DE69630727 T DE 69630727T DE 69630727 T DE69630727 T DE 69630727T DE 69630727 D1 DE69630727 D1 DE 69630727D1
Authority
DE
Germany
Prior art keywords
chitosan complex
cancer
radioactive
radiation therapy
radioactive chitosan
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69630727T
Other languages
English (en)
Other versions
DE69630727T2 (de
Inventor
Kyoung-Bae Park
Young-Mi Kim
Jae-Rock Kim
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Korea Atomic Energy Research Institute KAERI
Original Assignee
Korea Atomic Energy Research Institute KAERI
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Korea Atomic Energy Research Institute KAERI filed Critical Korea Atomic Energy Research Institute KAERI
Application granted granted Critical
Publication of DE69630727D1 publication Critical patent/DE69630727D1/de
Publication of DE69630727T2 publication Critical patent/DE69630727T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1217—Dispersions, suspensions, colloids, emulsions, e.g. perfluorinated emulsion, sols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/06—Macromolecular compounds, carriers being organic macromolecular compounds, i.e. organic oligomeric, polymeric, dendrimeric molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Optics & Photonics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Dispersion Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE69630727T 1995-03-10 1996-03-08 Radioaktiven Chitosankomplex und deren Anwendung in Strahlungstherapie Expired - Lifetime DE69630727T2 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
KR9504872 1995-03-10
KR19950004872 1995-03-10
KR9605038 1996-02-28
KR1019960005038A KR100190957B1 (ko) 1995-03-10 1996-02-28 방사성 키토산 착물, 방사성 키토산 응집입자 및 방사성키토산 착물 제조용 키트, 그리고 그들의 제조방법 및 용도

Publications (2)

Publication Number Publication Date
DE69630727D1 true DE69630727D1 (de) 2003-12-24
DE69630727T2 DE69630727T2 (de) 2004-09-30

Family

ID=26630908

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69630727T Expired - Lifetime DE69630727T2 (de) 1995-03-10 1996-03-08 Radioaktiven Chitosankomplex und deren Anwendung in Strahlungstherapie

Country Status (8)

Country Link
EP (1) EP0730871B1 (de)
JP (1) JP3048915B2 (de)
KR (1) KR100190957B1 (de)
CN (3) CN100528242C (de)
AT (1) ATE254481T1 (de)
DE (1) DE69630727T2 (de)
DK (1) DK0730871T3 (de)
PT (1) PT730871E (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6296831B1 (en) * 1998-04-10 2001-10-02 Battelle Memorial Institute Stimulus sensitive gel with radioisotope and methods of making
KR100530276B1 (ko) * 1998-10-12 2006-02-28 서울대학교병원 입자성 방사성핵종 포합 중합체, 그 제조방법 및 그 제조용킷트
US6660247B1 (en) 2000-06-23 2003-12-09 Battelle Memorial Institute Multiple stimulus reversible hydrogels
US20040197264A1 (en) * 2003-04-04 2004-10-07 Alexander Schwarz Microspheres comprising therapeutic and diagnostic radioactive isotopes
KR100700418B1 (ko) * 2003-09-08 2007-03-29 한국원자력연구소 방사성물질-키토산 복합체를 함유하는 전립선암 치료용조성물 및 조성물 제조용 키트
KR101080056B1 (ko) * 2004-12-01 2011-11-04 한국원자력연구원 체내 주사시 겔화 안정성이 개선된 방사성물질-키토산복합체용액 조성물 및 그 제조 방법
KR100704548B1 (ko) 2005-10-31 2007-04-09 한국과학기술연구원 염증 부위 특이적 고분자 유도체 및 그의 용도
CN100450553C (zh) * 2006-11-16 2009-01-14 沈阳 可降解放射性海绵及其制造工艺
NL2009688C2 (en) * 2012-10-24 2014-04-29 Nucletron Operations Bv A settable radioactive gel, a method of manufacturing a settable radioactive gel, a device for manufacturing a settable radioactive gel.
US10799587B2 (en) * 2016-05-11 2020-10-13 Huan NIU Ion implantation of neutron capture elements into nanodiamond particles to form composition for neutron capture therapy usage
CN107811752A (zh) * 2017-09-21 2018-03-20 温州医科大学 一种生物相容性青光眼房水引流管及其制备方法
KR101977185B1 (ko) * 2017-11-07 2019-05-10 한국원자력연구원 난치성 질환 치료 및 진단을 위한 생체 내 발생기 기능을 갖는 마이크로입자
MX2023003016A (es) * 2020-09-22 2023-04-10 Swimc Llc Composiciones de recubrimiento que contienen quitosana.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4385046A (en) * 1980-12-15 1983-05-24 Minnesota Mining And Manufacturing Company Diagnostic radio-labeled polysaccharide derivatives
JPH01211529A (ja) * 1988-02-19 1989-08-24 Tomoji Tanaka キチン、キトサン化合物を基材とした薬剤
US5061476A (en) * 1989-12-27 1991-10-29 The Dow Chemical Company Radiolabeled colloid compositions and method for preparing same
US5336415A (en) 1993-02-10 1994-08-09 Vanson L.P. Removing polyvalent metals from aqueous waste streams with chitosan and halogenating agents
JP3727074B2 (ja) * 1993-10-26 2005-12-14 日本メジフィジックス株式会社 局所投与放射線治療剤

Also Published As

Publication number Publication date
ATE254481T1 (de) 2003-12-15
JP3048915B2 (ja) 2000-06-05
CN1139116A (zh) 1997-01-01
CN1343521A (zh) 2002-04-10
KR960033472A (ko) 1996-10-22
CN1131072C (zh) 2003-12-17
EP0730871B1 (de) 2003-11-19
DK0730871T3 (da) 2004-07-26
CN1196498C (zh) 2005-04-13
JPH08311105A (ja) 1996-11-26
EP0730871A1 (de) 1996-09-11
DE69630727T2 (de) 2004-09-30
PT730871E (pt) 2004-07-30
CN100528242C (zh) 2009-08-19
KR100190957B1 (ko) 1999-06-15
CN1343522A (zh) 2002-04-10

Similar Documents

Publication Publication Date Title
US5484778C1 (en) Phthalocynine photosensitizers for photodynamic therapy and methods for their use
BR9915080A (pt) Fonte radioativa para uso em braquiterapia, métodos para a preparação de uma fonte radioativa e para tratamento de uma condição que responde à terapia de radiação, e, composição
DE69630727D1 (de) Radioaktiven Chitosankomplex und deren Anwendung in Strahlungstherapie
IE890343L (en) Ultrasonic contrast agents, process for their preparation and their use as diagnostic and therapeutic agents
IL83012A0 (en) Immunoconjugates for use in tumor therapy and their production
ID28003A (id) Turunan-turunan adamantana
GEP20002180B (en) Composition and Methods for Stimulating Megakaryocyte Growth and Differentiation
HK1024268A1 (en) Method for activating human antigen presenting cells, activated human antigen presenting cells, and use of the same.
EP0350230A3 (en) Immunoconjugates for cancer diagnosis and therapy
BG102657A (en) Method for radiation retention by means of fullerene molecules
NO178571C (no) Analogifremgangsmåte for fremstilling av et bifunksjonelt chelateringsmiddel
EP0173663A3 (en) The use of a specific tumor associated antigen, sialosyllactotetraose, in diagnostic or therapeutic procedures related to cancer deseases
HUP0100350A3 (en) Conjugates useful in the treatment of prostate cancer, pharmaceutical compositions comprising thereof, process for their preparation and their use
PL308074A1 (en) Derivatives of borone peptides, their production as well as their application in medical therapy
IL114382A (en) Lymphotoxin for use as a medicament for cancer therapy and use thereof in the manufacture of such medicament
WO1997005904A3 (de) Verwendung von metall-clustern als kontrastmittel oder strahlentherapeutikum
DE3684953D1 (de) Verwendung einer waessrigen chloritmatrix-loesung zur herstellung von arzneimitteln zur intravenoesen behandlung von tumoren.
GR3019776T3 (en) Antineoplastic medicament containing octadecyl-[2-(N-methylpiperidino)-ethyl] phosphate and synthesis thereof
RU94035764A (ru) Способ лечения онкологического заболевания
BG51097A1 (en) Process for the preparation of radiosensibilizing agent
ATE80800T1 (de) Verwendung von suramin und physiologisch vertraeglichen derivaten davon, gegebenenfalls in kombination mit anti-androgenen mitteln zur herstellung von arzneimitteln zur behandlung des humanen prostatakarzinoms.
JPS6464672A (en) Impact medical treatment device
BG51098A1 (en) Process for producing of radiosensibilizing compound

Legal Events

Date Code Title Description
8364 No opposition during term of opposition